3Shalev O,Hileti D,Nortey P,et al.Transport of 14C-deferiprone in normal,thalassaemic and sickle red blood cells.Br J Haematol,1999,105(4):1081-1083 被引量：1
4de Franceschi L,Shalev O,Piga A,et al.Deferiprone therapy in homozygous human beta-thalassemia removes erythrocyte membrane free iron and reduces KCl cotransport activity.J Lab Clin Med,1999,133(1):64-69 被引量：1
5Piga A,Gaglioti C,Fogliacco E,et al.Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major:a retrospective analysis.Hematologica,2003,88(5):489-496 被引量：1
6Olivieri NF,Brittenham GM,McLaren CE,et al.Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major.N Engl J Med,1998,339(7):417-423 被引量：1
7Tanner MA,Galanello R,Dessi C,et al.A randomized,placebo-controlled,double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia majo rusing cardiovascular magnetic resonance.Circulation,2007,115 (14):1876-1884 被引量：1
8Aydinok Y,Ulger Z,Nart D,et al.A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major.Haematologica,2007,92 (12):1599-1606 被引量：1
9Galanello R,Kattamis A,Piga A,et al.A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia.Haematologica,2006,91(9):1241-1243 被引量：1
10Ha SY,Chik KW,Ling SC,et al.A randomized controlled study evaluating the safety and efficacy of deferiprone treatment in thalassemia major patients from Hong Kong.Hemoglobin,2006,30(2):263-274 被引量：1
5Saiki PK,Bugawan TL,Horn GT,et al.Anlysis of enzy- metic amplified p-globin and HLA-DQ a with allele specific oligonucleotide probe[J].Nature,1986,324(13):163-169. 被引量：1
6Bang-Ce Y,Hongqiong L,Zhuanfong Z,et al Sinultaneous de- tection of alpha-thalassemia and beta-thalassemia by oligonu- cleotide microarray[J].Haematologica,2004,89(8):101. 被引量：1
7Lo YM,Tein MS,Lau TK,et al.Quantitative analysis of fe- tal DNA in maternal plasma and serum[J].Lancet,1997,350:485-487. 被引量：1
8Lo YM,Tein MS,Lau TK,et al.Quantitative analysis of fetal DNA in maternal plasma and serum implications for noninvasive prenatal diagnosis[J].Am J Hum Genet,1998,62:768-775. 被引量：1
9Anderson LJ,Worlke B,Prescott E,et al.Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentration and ventricular function in beta-thalassemia[J].The lancet,2002,360(9332):516-520. 被引量：1
10Angelucci E.Henatopoietic stem cell transplantation in thalassemia[J].Hematology Am Soc Hematol Educ Pro- gram,2010,456-462. 被引量：1
